搜尋
Mainz Biomed NV
MYNZ添加自選
0.844USD
0.0000.00%
收盤 07/01, 16:00（美東）報價延遲15分鐘
35.06M總市值
虧損本益比TTM
關於 Mainz Biomed NV 公司
Mainz Biomed N.V. is a Germany based molecular genetics cancer diagnostic company. The Company operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAlert, a colorectal cancer (CRC) screening stool-based DNA (deoxyribonucleic acid) test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, a platform technology to detect pathogens in environments on a molecular genetic basis. The Company competes with Exact Sciences, Epigenomics AG, Novigenix SA, GRAIL, Inc. and Agena Biosciences Inc.
Mainz Biomed NV簡介
公司代碼MYNZ
公司名稱Mainz Biomed NV
上市日期Nov 04, 2021
CEOBaechler (Guido)
員工數量19
證券類型Ordinary Share
年結日Nov 04
公司地址Sirius Gutenberg Park
城市MAINZ
上市交易所NASDAQ OMX - NASDAQ BASIC
國家Germany
郵編55129
電話496131265140
網址https://www.mainzbiomed.com/
公司代碼MYNZ
上市日期Nov 04, 2021
CEOBaechler (Guido)
Mainz Biomed NV公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Heiner Dreismann, Ph.D.
Dr. Heiner Dreismann, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
64.50K
+96.59%
Mr. Hans Hekland
Mr. Hans Hekland
Non-Executive Independent Director
Non-Executive Independent Director
56.00K
+68.27%
Mr. Gregory J. (Greg) Tibbitts
Mr. Gregory J. (Greg) Tibbitts
Non-Executive Independent Director
Non-Executive Independent Director
55.88K
+17.90%
Mr. Guido Baechler
Mr. Guido Baechler
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
6.36K
-9410.50%
Dr. Chris von Toerne
Dr. Chris von Toerne
Chief Operating Officer
Chief Operating Officer
2.50K
+93.24%
Mr. William Caragol
Mr. William Caragol
Chief Financial Officer
Chief Financial Officer
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Heiner Dreismann, Ph.D.
Dr. Heiner Dreismann, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
64.50K
+96.59%
Mr. Hans Hekland
Mr. Hans Hekland
Non-Executive Independent Director
Non-Executive Independent Director
56.00K
+68.27%
Mr. Gregory J. (Greg) Tibbitts
Mr. Gregory J. (Greg) Tibbitts
Non-Executive Independent Director
Non-Executive Independent Director
55.88K
+17.90%
Mr. Guido Baechler
Mr. Guido Baechler
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
6.36K
-9410.50%
Dr. Chris von Toerne
Dr. Chris von Toerne
Chief Operating Officer
Chief Operating Officer
2.50K
+93.24%
Mr. William Caragol
Mr. William Caragol
Chief Financial Officer
Chief Financial Officer
--
--
常見問題
Mainz Biomed NV的前五大股東是誰？
Mainz Biomed NV的前五大股東如下：Dr. Heiner Dreismann, Ph.D.
有多少機構持有Mainz Biomed NV(MYNZ)的股份？
截至2026Q1，共有33家機構持有Mainz Biomed NV的股份，合計持有的股份價值約為1.23M，占公司總股份的9.84% 。與2025Q4相比，機構持股有所增加，增幅為663009.00。